Charles River Laboratories International, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| RV6.F | 603127.SS | ICLR | 3347.HK | MEDP | SYNGENE.BO | |
|---|---|---|---|---|---|---|
| Market cap | 13.79B | 34.88B | 15.22B | 35.23B | 18.37B | 166.51B |
| P/E (TTM) | 356.5 | 30.4 | 81.2 | — | 36.5 | 89.7 |
| Forward P/E | 24.9 | 105.8 | 17.5 | 30.2 | 33.1 | 40.6 |
| Price/book | 5.0 | 3.7 | 1.7 | 1.5 | 31.4 | 3.4 |
| Dividend yield | — | 0.27% | — | 0.36% | — | 0.30% |
| 1-year change | +94.94% | +32.91% | +24.48% | −8.54% | +10.80% | −37.12% |
| Today | −2.17% | +5.56% | −0.32% | +2.28% | −1.01% | −0.70% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All RV6.F news ›Charles River Laboratories International, Inc. (CRL) Q3 2026 Earnings Call Transcript
Charles River Laboratories International, Inc. (CRL) Q3 2026 Earnings Call November 4, 2026 9:00 AM ESTCompany ParticipantsTodd Spencer - Corporate Vice... Charles River Laboratories International, Inc. (CRL) Q3 2026 Earnings Call November…
More from 1 other outlet
Charles River Laboratories International (CRL) Projected to Post Quarterly Earnings on Wednesday
Charles River Laboratories International (NYSE:CRL – Get Free Report) is expected to be issuing its Q3 2026 results before the market opens on Wednesday, November 4th. Analysts expect the company to post earnings of $2.97 per share and…
Charles River Laboratories International (NYSE:CRL) Director James Foster Sells 24,042 Shares of Company Stock
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) Director James Foster sold 24,042 shares of the company’s stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $350.00,…
Charles River Laboratories International, Inc. $CRL Stock Position Raised by Signaturefd LLC
Signaturefd LLC boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 563.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange…
Charles River Laboratories International (NYSE:CRL) Stock: Insider Shannon Parisotto Sells 2,156 Shares
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) EVP Shannon Parisotto sold 2,156 shares of the company’s stock in a transaction on Wednesday, October 21st. The shares were sold at an average price of $344.41,…
Charles River Laboratories International Jumps 7.3% in Broad Rally
AlphaStreet publishes free earnings call transcripts, earnings previews, and financial analysis for S&P 1500 companies. Transcripts are published within few minutes of every conference call - faster than any other source. AlphaStreet…
Is Charles River Laboratories International Inc (CRL) Overvalued After 5.1% Rally? GF Value Says Overvalued
On October 20, 2026, Charles River Laboratories International Inc CRL shares rose 5.1% to a current price of $315.45. The stock has seen a significant price increase over the past year, with a 52-week high of $333.30 and a low of $146.20.…
Magellan Stem Cells Collaborates with Charles River Laboratories International, Inc. to Advance Stem Cell and Regenerative Medicine Development
Charles River Laboratories International, Inc. and Magellan Stem Cells announced their collaboration to support Magellan in the development and clinical advancement of its proprietary stem cell-based... Charles River Laboratories…
Charles River Laboratories International, Inc.: Relative Strength Chart - Stock NYSE
Compare Charles River Laboratories International, Inc. with the company of your choice via a Relative Strength chart. Real-time CRL price, NYSE stock exchange Relative Strength Chart Charles River Laboratories International, Inc.…
UBS Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $357 From $175
Charles River Laboratories International has an average rating of buy and mean price target of $423.54, according to analysts polled by FactSet. ... Charles River Laboratories International, Inc. Biotechnology & Medical Research UBS…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com12
- defenseworld.net2
- gurufocus.com2
- themarketsdaily.com2
- kalkinemedia.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 22 articles, not a forecast.